IRIS
BONDAVALLI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.562
AS - Asia 1.703
NA - Nord America 1.247
SA - Sud America 144
Continente sconosciuto - Info sul continente non disponibili 105
AF - Africa 17
OC - Oceania 1
Totale 18.779
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 15.297
US - Stati Uniti d'America 1.164
SG - Singapore 720
CN - Cina 447
VN - Vietnam 296
FR - Francia 129
BR - Brasile 95
BD - Bangladesh 74
HK - Hong Kong 72
DE - Germania 36
FI - Finlandia 29
CA - Canada 28
JP - Giappone 22
GB - Regno Unito 21
AR - Argentina 18
MX - Messico 16
JM - Giamaica 13
IN - India 11
EC - Ecuador 10
NL - Olanda 9
VE - Venezuela 8
ES - Italia 7
PH - Filippine 7
TH - Thailandia 7
ID - Indonesia 6
CH - Svizzera 5
CO - Colombia 5
IE - Irlanda 5
KR - Corea 5
PR - Porto Rico 5
RU - Federazione Russa 5
ZA - Sudafrica 5
CR - Costa Rica 4
IQ - Iraq 4
PL - Polonia 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
CL - Cile 3
DO - Repubblica Dominicana 3
HN - Honduras 3
HR - Croazia 3
PK - Pakistan 3
TR - Turchia 3
TW - Taiwan 3
BB - Barbados 2
BS - Bahamas 2
EE - Estonia 2
GT - Guatemala 2
JO - Giordania 2
KE - Kenya 2
KH - Cambogia 2
LC - Santa Lucia 2
MA - Marocco 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
PT - Portogallo 2
SC - Seychelles 2
SE - Svezia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CM - Camerun 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ET - Etiopia 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
MM - Myanmar 1
OM - Oman 1
PY - Paraguay 1
RO - Romania 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
UA - Ucraina 1
UY - Uruguay 1
Totale 18.674
Salva come PNG Salva come JPEG
Città #
Genova 9.467
Genoa 3.470
Rapallo 1.383
Vado Ligure 896
Singapore 357
San Jose 344
Lauterbourg 121
Ashburn 84
Ho Chi Minh City 84
Beijing 73
New York 73
Hong Kong 67
Hanoi 64
Frankfurt am Main 34
Santa Clara 30
Helsinki 29
Tokyo 19
Chicago 18
Los Angeles 18
Haiphong 17
Bordighera 14
Dallas 11
Orem 11
São Paulo 11
Tianjin 11
Amsterdam 9
Da Nang 9
Des Moines 9
Memphis 9
Mexico City 9
Naples 9
Rome 9
Atlanta 8
Council Bluffs 8
Houston 8
Milan 8
Cardiff 7
Kingston 7
London 7
Quito 7
Seattle 7
Toronto 7
Can Tho 6
Denver 6
Biên Hòa 5
Bossier City 5
Buenos Aires 5
Buffalo 5
Dublin 5
Montego Bay 5
Philadelphia 5
Boardman 4
Brooklyn 4
Campinas 4
Curitiba 4
Hixson 4
Jeddah 4
Kansas City 4
Las Vegas 4
Louisville 4
Miami 4
Newark 4
Rochester 4
San José 4
Shanghai 4
South Jordan 4
Wuhan 4
Zurich 4
Augusta 3
Baghdad 3
Baku 3
Bangkok 3
Belo Horizonte 3
Bắc Ninh 3
Charlotte 3
City of London 3
Decatur 3
Edinburg 3
Henderson 3
Hải Dương 3
Jacksonville 3
Johannesburg 3
Lancaster 3
Lawrenceville 3
Montreal 3
Phoenix 3
Phủ Lý 3
Pittsburgh 3
Richmond 3
Rio de Janeiro 3
Salvador 3
San Antonio 3
Stockton 3
Warsaw 3
Washington 3
Zagreb 3
Abilene 2
Amman 2
Aurora 2
Baltimore 2
Totale 17.050
Salva come PNG Salva come JPEG
Nome #
An efficient synthesis of functionalized 2-pyridones by direct route or via amide/enolate ammonium salt intermediates 214
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 197
Affinity prediction on A1 adenosine receptor agonists: the chemometric approach 195
Synthesis and 3D QSAR of new pyrazolo[3,4-b]pyridines: potent and selective inhibitors of A1 adenosine receptors 188
1-Acyl-, 3-acyl- and 1,3-diacyl-3-furfuryl-1-phenylthioureas with platelet antiaggregating and other activities. 185
Synthesis and biological evaluation of neutrophilic inflammation inhibitors 184
3-Arylsulphonyl-5-arylamino-1,3,4-thiadiazol-2(3H)ones as antiinflammatory and analgesic agents 182
. 3,5-diphenyl-1H-pyrazole derivatives. XI. N-aryl-5(3)-phenyl-4-(3,5- diphenyl-1-pyrazolyl)-3(5)-pyrazole amines, 5-substituted 4,5-dihydro-3-phenyl-4-(3,5-diphenyl-1-pyrazolyl)-1H-pyrazoles and 2,6-disubstituted 1,6-dihydro-4- phenyl-5-(3,5-diphenyl-1-pyrazolyl)pyrimidines with antipyretic, antiinflammatory and other activities. 181
2-Aryl-3-phenylamino-4,5-dihydro-2h-benz[g]indazoles with analgesic activity 180
A chemometric approach to predict A1 agonist effect of adenosine analogues 177
Structure-based optimization of pyrazolo[3,4-d]pyrimidines as Abl inhibitors and antiproliferative agents toward human leukemia cell lines 175
3,5-Diphenyl-1H-pyrazole derivatives. IX. 2-substituted 4-phenyl-5-(3,5-diphenyl-1H-pyrazol-1-yl) pyrimidines with platelet antiaggregating and other activities. 175
3,5-Diphenyl-1H-pyrazole derivatives. V--1-Acetyl-4-hydroxy-3,5-diphenyl-2-pyrazoline esters, 4-hydroxy-3,5-diphenyl-1H-pyrazole esters and N-substituted 4-(3-amino-2-hydroxy-1-propoxy)-1-methyl-3,5-diphenyl-1H-pyrazoles with antiarrhythmic, sedative and platelet antiaggregating activities. 172
3,3-disubstituted 1-acyl-1-phenylthioureas with platelet antiaggregating and other activities 167
Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line 166
Synthesis and biological evaluation of N-pyrazolyl-N'-alkyl/benzyl/phenylureas: a new class of potent inhibitors of interleukin 8-induced neutrophil chemotaxis 165
3,5-Diphenyl-1H-pyrazole derivatives. III. Ethers 1-(2-hydroxyethyl)-3,5-diphenyl-1H-pyrazole and its 4-bromo derivative with hypotensive, depressant, antiarrhythmic and analgesic activities 163
2-Phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives: New potent inhibitors of fMLP-induced neutrophil chemotaxis 163
Synthesis and pharmacological activity of derivatives of exo- trimethylenenorbornane. I 161
2- And 5-substituted 5-amino-2,6,6-trimethyltetrahydropyrans 159
N'-acyl-N,N-(1,3,3-trimethylbicyclo [2.2.1]hept-2-ylidene)benzamidines with hypotensive activity. 158
2-Amino/Azido/Hydrazino-5-alkoxy-5H-[1]benzopyrano[4,3-d]pyrimidines: Synthesis and Pharmacological Evaluation 158
Derivati dell'1,3-benzodiossolo, potenziali inibitori delle PDE5 157
Synthesis and reactivity of (1S,4S,5S) -5-bromo-1,3,3-trimethyl-N-nitro-2-oxabicyclo[2.2.2]octan-6-imine. X Ray-molecular structure and absolute configuration of E and Z isomers of (1S,4S)-5,5-dibromo-1,3,3-trimethyl-N-nitro-2-oxabicyclo[2.2.2]octan-6-imine, the first case of separated nitrimine isomers. 157
Carbonyl transposition and regio- and stereo-specific syntheses of new alcohols, amino-alcohols and ketones in the monoterpenoid 1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane 157
2-aryl-3-phenylamino-4,5-dihydro-2H-benz[g]indazoles with antiarrhythmic and local anaesthetic activities 155
N-Acyl-N-phenyl ureas of piperidine and substituted piperidines endowed with antiinflammatory and antiproliferative activities 154
Synthesis and pharmacological evaluation of 5H-[1]benzopyrano[4,3-d]pyrimidines effective as antiplatelet/analgesic agents 154
New pyrazolo[3,4-d]pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylation 154
Antiinflammatory agents: new series of N-substituted amino acids with complex pyrimidine structures endowed with antiphlogistic activity 153
3-(Arylamino)-6,7-dihydro-6-methylpyrano[4,3-c]pyrazol-4(1H or 2H)-ones with antipyretic, analgesic, antiarrhythmic, hypotensive and other activities. 152
Synthesis, molecular modeling studies and pharmacological activity of selective A1 receptor antagonists 151
3,5-Diphenyl-1H-pyrazole derivatives. IV--N,N-disubstituted 3-(3,5-diphenyl-1H-pyrazol-1-yl)propanamides and 3-(3,5-diphenyl-1H-pyrazol-1-yl)propanamines with sedative, platelet antiaggregating and local anesthetic activities. 148
N-acyl-N'-methyl-N-(1,3,3-trimethylbicyclo[2.2.1]hept-2-yl) benzamidines with hypotensive activity. 147
4-Amino-pyrazolo[3,4-d]pyrimidines with antiproliferative activity on osteosarcoma cell line SaOS-2 147
3,5-Diphenyl-1H-pyrazole derivatives. I--Esters and N-substituted carbamates of 1-(2-hydroxyethyl)-3,5-diphenyl-1H-pyrazole and its 4-bromo derivative with depressant, antiarrhythmic, analgesic and other activities. 145
3,5-Diphenyl-1H-pyrazole derivatives. II--N-substituted 1-(2-aminoethyl)-3,5-diphenyl-1H-pyrazoles and their 4-bromo derivatives with analgesic and other activities 145
Unprecedented one-pot stereoselective synthesis of Knoevenagel-type derivatives via in situ condensation of N-methyleniminium salts of ethylenethiourea and ethyleneurea with active methylene reagents 144
2-Aryl-6-methyl-3-phenylamino-6,7-dihydropyrano[4,3-c]pyrazol-4(2H)-ones with analgesic activity. 144
Exploring the molecular basis of selectivity in A1 adenosine receptors antagonist: a case study 143
Structure-based Design, Parallel Synthesis, SAR and Molecular Modelling Studies of Thiocarbamates, New Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitor Isosteres of Phenethylthiazolylthiourea Derivatives. 142
New halogenated 4-aminopyrazolo[3,4-b]pyridines A1 adenosine receptor ligands 142
3,5-Diphenyl-1H-pyrazole derivatives. VI Esters and 2-dialkylaminoethyl ethers of 1(2-hydroxy-2-phenylethyl)-3,5-diphenyl-1H-pyrazole and N,N-disubstituted 1-(2-amino-2-phenylethyl)-3,5-diphenyl-1H-pyrazoles with depressant and platelet antiaggregating activities. 142
2,3-Dihydro-1H-imidazo[1,2-b]pyrazole derivatives as potential neutrophils functions inhibitors 141
Antiangiogenic agents: an update on small molecule VEGFR inhibitors 140
3,5-Diphenyl-1H-pyrazole derivatives. VII--Esters, 2-dialkylaminoethyl ethers and N-substituted carbamates of 1-(2-hydroxy-3-phenoxypropyl)-3,5-diphenyl-1H-pyrazole with depressant and platelet antiaggregating activities 140
omega-Dialkylaminoalkyl esters of 3-dialkylamino-4,7,7-trimethyl-N-phenylbicyclo[2.2.1] hept-2-ene-2-iminothiolic acids with local anesthetic activity. 139
Preparation of new 5-aroylamino substituted 3-nicotinoyl/isonicotinoyl-1,3,4-thiadiazol-2(3H)-ones with anti-inflammatory activity 139
3,5-Diphenyl-1H-pyrazole derivatives. XII. N-substituted 4-amino-1-(2-hydroxy- or 2-alkylaminoethyl)-3,5-diphenyl-1H-pyrazoles with local anesthetic, analgesic and platelet antiaggregating activities. 139
5-alkoxy-2-hydrazino and 5-methoxy-2-amino-5H-[1]benzopyrano[4,3-d]pyrimidines: synthesis and pharmacological activity 138
Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists: synthesis, biological evaluation, and development of an A1 bovine receptor model. 137
Synthesis and pharmacological evaluation of 2,5-Cycloamino-5H[1]benzopyrano[4,3-d]pyrimidines endowed with in vitro antiplatelet activity 137
Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation 136
Pyrazolo[3,4-d]pyrimidines endowed with antiproliferative activity on ductal infiltrating carcinoma cells 132
Synthesis of 6-thiosubstituted 5-ethoxycarbonyl-1,3-diphenyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-ones, 6-substituted 5-hydroxy-1,3-diphenyl-2,3-dihydrothieno[2,3-d]pyrimidin-4(1H)-ones and their esters with local anesthetic, antiarrhythmic, antiinflammatory and analgesic activities. 132
Synthesis and anti-inflammatory activity of esters derived from 5-aryl-1,2-dihydro-2-(2-hydroxyethyl)-3H-1,2,4-triazole-3-thiones 132
New 1,3,4-thiadiazole derivatives endowed with analgesic and anti-inflammatory activities 132
Synthesis of 1-(2-chloro-2-phenylethyl)-6-methylthio-1-H-pyrazolo[3,4-d]pyrimidines 4-amino substituted and their biological evaluation 131
4-Amino-substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and their preparation, pharmaceutical composistion and use antitumor and antileukemic agents 131
3,5-Diphenyl-1H-pyrazole derivatives. VIII. N-substituted 3-(4-hydroxy-3,5-diphenyl-1H-pyrazol-1-yl)-propanamides, -propanamines and 2-(4-hydroxy-3,5-diphenyl-1H-pyrazol-1-yl)ethanamines with platelet antiaggregating, hypotensive, antiarrhythmic and other activities. 131
Derivatives of 4,5,6,7-Tetrahydro-7,8,8-trimethyl-3-phenylamino-4,7-methano-2H-Indazole with hypoglycemic and hypotensive activities 131
Derivatives of 5,7,7-trimethyl-6-oxa-3-azabicyclo[3.2.2]nonane with antiarrhythmic, local anesthetic and hypotensive activities. II 130
Derivatives of 5,7,7-trimethyl-6-oxa-3-azabicyclo[3.2.2]nonane with antiarrhythmic, local anesthetic and hypotensive activities 130
5-[[ω-(Dialkylamino)alkoxy]methylene]-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-6-ones with hypotensive, local anesthetic, antiarrhythmic and other activities 130
N-Substituted O-(3-amino-2-hydroxypropyl)oximes of 1,3,3-trimethyl-5-endo-(1-piperidinyl or 4-morpholinyl)-2-oxabicyclo[2.2.2]octan-6-ones with platelet antiaggregating and local anesthetic activities 129
The reaction of Terpenoid Nitrimines with secondary amines; a new route to Terpenoid Enamines 129
Synthesis and biological data of 4-amino-1-(2-chloro-2-phenylethyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid ethyl esters, a new series of A1-adenosine receptor (A1AR) ligands 126
Design, synthesis, SAR, and molecular modeling studies of acylthiocarbamates: a novel series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors structurally related to phenethylthiazolylthiourea derivatives 125
N-Substituted 3-(arylamino)-4,5-dihydro-2H-benz[g]indazol-2-yl acetamides with antiinflammatory and analgesic activities 124
Synthesis, antiplatelet and antithrombotic activities of new 2-substituted benzopyrano[4,3-d]pyrimidin-4-cycloamines and 4-amino/cycloamino-benzopyrano[4,3-d]pyrimidin-5-ones  124
Syntheses of 1,3,3-trimethyl-2-oxabicyclo[2.2.2]oct-5-ene(2,3-didehydro-1, 8-cineole), 6,6-dimethyl-2-methylene-7-oxabicyclo[3.2.1]octane (Isopinol), 2,6,6-trimethyl-7-oxabicyclo[1.2.1]oct-2-ene (Pinol) and 1-(3-isopropylidenecyclopentyl)ethanone (Pinolone) from hydroxy- and bromo-derivatives of Cineole 124
Reduction of 6-hydroxyimino-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane and nitrosation of the resulting amines. New rearrangement products of the monoterpenoid 1,3,3-trimethyl-2-oxabicyclo [2.2.2]octane 124
O-[2-Hydroxy-3-(dialkylamino)propyl]ethers of (+)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one oxime (camphor oxime) with analgesic and antiarrhythmic activities 123
New pyrazolo[3,4-b]pyridones as selective A1 adenosine receptor antagonists: synthesis, biological evaluation and molecular modeling studies 122
Bamford-Stevens reaction of (+)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-6-one p-tolylsulphonylhydrazone 121
N-acyl-4,7,7-trimethyl-N-phenyl-3-(1-piperidinyl or dimethylamino)bicyclo[2.2.1]hept-2-ene-2-carbothioamides with platelet antiaggregating and other activities. 121
Synthesis of new 2-phenyl-1-arylcarbamoyl-2,3-dihydro-1h-imidazo[1,2-b]pyrazoles 7-substituted as potential neutrophil chemotaxis inhibitors 120
3,5-Diphenyl-1H-pyrazole derivatives. X. N-substituted 1-(2-aminopropyl)- and 1-(3-amino-2-hydroxypropyl)-3,5-diphenyl-1H-pyrazoles with antiinflammatory and other activities. 120
Modulazioni Strutturali in O-[2-(N-Ftalimmido)etil] Acil(Aril)Tiocarbammati, Inibitori Non-Nucleosidici della Transcrittasi Inversa di HIV-1 118
4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 118
Synthesis of new pyrazolo [3,4-d]pyrimidines Bcr-Abl tyrosine kinase inhibitors 118
N-arylsubstituted-1-aryl-3,4-diphenyl-5-pyrazole amines with analgesic and antiarrhythmic properties. 118
Progress in 5H-[1]benzopyrano[4,3-d]pyrimidin-5-amine series: 2-methoxy derivatives effective as antiplatelet agents with analgesic activity 118
Synthesis of 3-Cyclopentyloxy-4-methoxy-N-(cycloalkylamino-1-yl)-benzamides and related compounds as new Rolipram-analogues 118
null 117
5-Substituted 2,3-dihydro-6-mercapto-1,3-diphenyl-2-thioxo-4(3H)-pyrimidinones and their 6-(acylthio) derivatives with platelet antiaggregating, antiinflammatory, antiarrhythmic, antihyperlipidemic and other activities. 117
Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines 117
New rolipram related PDE4 inhibitors: synthesis, enantiomers separation and enzymatic activity 116
N-Monosubstituted Urethanes and Esters of 6-cis-Dimethylamino-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-5-trans-ol with hypotensive and other activities 116
null 116
Preparation of ureidopyrazolecarboxylates with neutrophil chemotaxis inhibiting activity. 115
New pyrazolo[3,4-d]pyrimidines 4-benzylamino substituted endowed with antiproliferative activity on chronic myeloid leukemia cell line 115
Synthesis of pyrazolo[3,4-d]pyridines selective antagonists of A1 adenosine receptors 115
Derivatives of 1,3,3-Trimethyl-6-azabicyclo[3.2.1]octane with hypotensive activity 115
N-substituted ureas of ethyl 1-(2-hydroxy-2-phenylethyl)-1H-pyrazole-4-carboxylate as potent and selective IL-8 receptor inhibitors 114
New selective PDE4D inhibitors able to discriminate between long, short and supershort isoforms 114
Reactions of the potassium salt of 1,7,7-trimethyl-N-nitrobicyclo[2.2.1] heptan-2-imine with bromine and nitrous acid: Synthesis of 3-exo-bromo-1,7,7-trimethyl-N-nitrobicyclo[2.2.1]heptan-2-imine, 3-endo-bromo-1,7,7-trimethyl-N-nitrobicyclo[2.2.1]heptan-2-imine, 1,7,7-trimethyl-N-nitro-3-nitrosobicyclo[2.2.1]hept-2-en-2-amine and their reactions with nitrogen nucleophiles. 114
Esters of 6-Cis-dialkyilamino-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-5-trans-ols with hypotensive and other activities 112
ω-Dialkylaminoalkyl ethers of 6-(benzyl or phenyl)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-6-ol with platelet antiaggregating and local anesthetic activities 111
3-Hydroxyiminocamphornitrimine and Camphorquinone Dinitrimine, Compounds previously described as N-Nitro-3-nitrosocamphorenamine.and N-Nitro-N,3-Dinitrosocamphorenamine. Crystal Structure of Camphorquinone Dinitrimine. 110
Totale 14.100
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.594
article - articoli 47.083
book - libri 0
conference - conferenze 9.729
curatela - curatele 0
other - altro 0
patent - brevetti 1.782
selected - selezionate 0
volume - volumi 0
Totale 117.188
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.646 31 154 95 250 54 110 158 348 40 128 79 199
2022/20231.667 181 101 16 170 320 307 0 113 275 11 152 21
2023/2024808 39 134 12 100 76 159 30 27 57 7 43 124
2024/20252.196 33 185 66 164 285 240 141 331 85 93 242 331
2025/20264.107 524 87 256 352 525 468 706 168 238 452 189 142
2026/2027443 443 0 0 0 0 0 0 0 0 0 0 0
Totale 18.779